U.S. markets open in 2 hours 16 minutes

ShockWave Medical, Inc. (SWAV)

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Add to watchlist
92.73-5.69 (-5.78%)
At close: 4:00PM EST

92.73 0.00 (0.00%)
Pre-Market: 6:01AM EST

Full screen
Trade prices are not sourced from all markets
Gain actionable insight from technical analysis on financial instruments, to help optimize your trading strategies
Chart Events
Bearishpattern detected
Williams %R

Williams %R

Previous Close98.42
Open99.04
Bid90.00 x 900
Ask0.00 x 900
Day's Range91.46 - 99.79
52 Week Range22.01 - 143.79
Volume498,645
Avg. Volume422,947
Market Cap3.231B
Beta (5Y Monthly)1.22
PE Ratio (TTM)N/A
EPS (TTM)-1.99
Earnings DateMay 10, 2021 - May 14, 2021
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target Est139.20
Fair Value is the appropriate price for the shares of a company, based on its earnings and growth rate also interpreted as when P/E Ratio = Growth Rate. Estimated return represents the projected annual return you might expect after purchasing shares in the company and holding them over the default time horizon of 5 years, based on the EPS growth rate that we have projected.
Fair Value
XX.XX
Overvalued
Research that delivers an independent perspective, consistent methodology and actionable insight
Related Research
View more
  • Motley Fool

    Shockwave Medical Has Captured Just a Fraction of Its $6 Billion Market Potential

    Shockwave Medical (NASDAQ: SWAV) posted substantial increases in revenue in the fourth quarter. In this video from Motley Fool Live, recorded on Feb. 22, Fool.com Contributors Brian Orelli and Keith Speights discuss Shockwave's most recent quarter and the opportunities ahead for the medical-device maker. Brian Orelli: Then moving on to Shockwave Medical, which develops treatments to break down calcium deposits in arteries.

  • Motley Fool

    Shockwave Medical Continues to Execute on Its Growth Plans

    Owning small-cap companies can be a little nerve-racking, especially if it's a medical device company that's waiting on FDA approval. For Shockwave Medical (NASDAQ: SWAV) investors, the wait is over. It received the go-ahead from the FDA for its coronary artery disease device this past month.

  • Motley Fool

    How to Sleep Soundly When One of Your Big Stocks Has a Really Bad Day

    In this video clip from Motley Fool Live, recorded on Feb. 18, Fool.com contributors Brian Feroldi, Brian Withers, and Matt Frankel, CFP, discuss how to sleep soundly even when your portfolio loses $10,000 over the course of a few days. Matt Frankel: I see a question that I'd really like to address because it's a very important concept.